The advent of induced pluripotent stem cells (iPSCs) could be key to addressing this challenge, with iPSCs offering the potential for self-renewal and pluridirectional differentiation. iPSCs can ...

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...

The northern white rhinoceros is one of the rarest animals on Earth, with just two females left and no natural way for the ...

Japan has been promoting regenerative medicine using induced pluripotent stem cells, or iPS cells, as a national strategy.<br />That research has led to some promising results, including a possible ...

Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

Pediatric pilocytic astrocytoma (PA) is a common type of low-grade brain tumor in children, influenced by specific genetic ...

OSAKA, Japan >> Exhibitions where visitors can experience advanced technology are attracting big crowds at the 2025 ...

Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Ital ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

Financially, Creative Medical has limited cash reserves, high cash burn, and will likely need dilutive financing. Click here ...